Not checked for notices yet.
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Christopher J. LaRocca, Susanne G. Warner
Clinical and Translational Medicine · 2018
Cited by papers we hold 4
- Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy · 2021No notice
- Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy · 2021No notice
- Stem cell programs in cancer initiation, progression, and therapy resistance · 2020No notice
- Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.